Unbound MEDLINE

Vancomycin and Daptomycin Pharmacodynamics Differ Against a Site-Directed Staphylococcus epidermidis Mutant Displaying the Small Colony Variant Phenotype. Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] Journal article

 
TitleVancomycin and Daptomycin Pharmacodynamics Differ Against a Site-Directed Staphylococcus epidermidis Mutant Displaying the Small Colony Variant Phenotype.
Author(s)Wu M, von Eiff C, Al Laham N, Tsuji BT 
InstitutionLaboratory for Antimicrobial Pharmacodynamics, School of Pharmacy and Pharmaceutical Sciences Buffalo and The New York State Center of Excellence in Bioinformatics & Life Sciences, University at Buffalo, New York 14260; Institute of Medical Microbiology, University of Münster, Münster, Germany; Roswell Park Cancer Institute Department of Medicine, Buffalo, NY, 14260.
SourceAntimicrob Agents Chemother 2009 Jun 29.
AbstractCatheter-related bloodstream infections due to slow-growing Staphylococcus epidermidis small colony variants (SCVs) are extremely difficult-to-treat. Daptomycin and vancomycin pharmacodynamics were evaluated against a site directed hemB mutant of S. epidermidis displaying the SCV phenotype and compared to the parental strain. Maximal effect decreased by 7.7-fold for vancomycin and 1.5-fold for daptomycin against the SCV mutant which was well characterized by a hill type mathematical model (R(2) >0.97).
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19564372
  
Advertise on this site.